Defining the level of evidence for technology adoption in the localized prostate cancer pathway.

Details

Ressource 1Request a copy Sous embargo indéterminé.
State: Public
Version: Final published version
Serval ID
serval:BIB_AD52F90960C9
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Defining the level of evidence for technology adoption in the localized prostate cancer pathway.
Journal
Urologic Oncology
Author(s)
Valerio M., El-Shater Bosaily A., Emberton M., Ahmed H.U.
ISSN
1873-2496 (Electronic)
ISSN-L
1078-1439
Publication state
Published
Issued date
2014
Peer-reviewed
Oui
Volume
32
Number
6
Pages
924-930
Language
english
Notes
Publication types: REVIEW Publication Status: ppublish PDF: Seminar article
Abstract
New technologies in prostate cancer are attempting to change the current prostate cancer pathway by aiming to reduce harms while maintaining the benefits associated with screening, diagnosis, and treatment. In this article, we discuss the optimal evaluation that new technologies should undergo to provide level 1 evidence typically required to change the practice. With this in mind, we focus on feasible and pragmatic trials that could be delivered in a timely fashion by many centers while retaining primary outcomes that focus on clinically meaningful outcomes.
Pubmed
Web of science
Open Access
Yes
Create date
05/09/2014 18:11
Last modification date
20/08/2019 16:17
Usage data